| Autor: |
Leneva, I., Glushkov, R., Gus'kova, T. |
| Předmět: |
|
| Zdroj: |
Pharmaceutical Chemistry Journal; Nov2004, Vol. 38 Issue 11, p590-596, 7p |
| Abstrakt: |
This article presents information on drugs for chemotherapy and prophylaxis of influenza. At present, the chemotherapy and prophylaxis of influenza all around the world are based mostly on drugs of the adamantine groups (amantadine and remantadine) and neuraminidase inhibitors (zanamivir and ozeltamivir). The World Health Organization (WHO) recommended vaccination as the main means of fighting influenza, but this approach showed a rather limited efficacy because the influenza virus is subject to rapid and unpredictable variations occurring in two ways. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
